ORIGINAL ARTICLE

Relationship between Interleukin-18 (IL-18) level and Mean Platelet Volume (MPV) with ischemic stroke event in Sanglah General Hospital, Bali, Indonesia

Anak Agung Ngurah Subawa , Dewa Putu Gde Purwa Samatra, Desak Gde Diah Dharma Santhi

Anak Agung Ngurah Subawa
Department of Clinical Pathology, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital, Denpasar, Bali. Email: drsubawa@yahoo.com

Dewa Putu Gde Purwa Samatra
Department of Neurology, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital, Denpasar, Bali

Desak Gde Diah Dharma Santhi
Department of Clinical Pathology, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital, Denpasar, Bali
Online First: July 11, 2020 | Cite this Article
Subawa, A., Samatra, D., Santhi, D. 2020. Relationship between Interleukin-18 (IL-18) level and Mean Platelet Volume (MPV) with ischemic stroke event in Sanglah General Hospital, Bali, Indonesia. Bali Medical Journal 9(2). DOI:10.15562/bmj.v9i2.1869


Background: Long-term stroke risk factors may lead to inflammation of endothelial vessels characterized by migration of macrophages and T-lymphocytes in blood vessel walls by releasing Interleukin-18 (IL-18) cytokines and causing changes in Mean Platelet Volume (MPV) values. This study aims to determine the relationship between IL-18 and MPV levels with ischemic stroke event in Sanglah General Hospital Denpasar.

Methods: A matched-pair case-control study design was conducted in this study. The number of stroke and control samples were 33 people, respectively, and the dependent variable was an ischemic stroke, following MPV and IL-18 as dependent variables. Free T-2 sample test used to compare MPV in each group while the Mann-Whitney test used to compare the interleukin levels of the two groups. Data were analyzed using SPSS version 20 for Windows.

Results: The MPV value of ischemic stroke patients was significantly higher (8.5±1.19 fL), whereas the MPV value at control was 0.00±0.44 fL (p<0.05). The levels of IL-18 were statistically significantly higher in stroke patients (450.71±278.82 pg/ml) compared with controls (221.46 ± 127.83 pg/ml) (p<0.05). With the Spearman correlation test, there was a significant moderate negative correlation between MPV value and ischemic stroke (r=-0.357; p=0.003) as well as IL-18 and ischemic stroke (r=-0.492;p=0.000).

Conclusion: Our study suggests that there was a significant relationship between MPV and IL-18 value and ischemic stroke event at Sanglah General Hospital, Bali, Indonesia

References

Hinkle JL, Guanci MM. Acute ischemic stroke review. J Neurosci Nurs. 2007;39(5):285-310.

Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67(2):181-198.

Boehme AK, Esenwa C, Elkind MS. Stroke Risk Factors, Genetics, and Prevention. Circ Res. 2017;120(3):472-495.

Donkor ES. Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life. Stroke Res Treat. 2018;2018:3238165.

Ovbiagele B, Nguyen-Huynh MN. Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics. 2011;8(3):319-329.

Kusuma Y, Venketasubramanian N, Kiemas LS, Misbach J. Burden of stroke in Indonesia. Int J Stroke. 2009;4(5):379-380.

Otsuka F, Yasuda S, Noguchi T, Ishibashi-Ueda H. Pathology of coronary atherosclerosis and thrombosis. Cardiovasc Diagn Ther. 2016;6(4):396-408.

Varol E, Ozaydin M, Türker Y, Alaca S. Mean platelet volume, an indicator of platelet activation, is increased in patients with mitral stenosis and sinus rhythm. Scand J Clin Lab Invest. 2009;69(6):708-712.

Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets. 2002;13(5-6):301-306.

Dogan NO, Keles A, Aksel G, Guler S, Demircan A, Bildik F, et al. Mean platelet volume as a risk stratification tool in the emergency department for evaluating patients with ischaemic Stroke and TIA. J Pak Med Assoc. 2013;63(5):581-584.

Smyth DW, Martin JF, Michalis L, Bucknall CA, Jewitt DE. Influence of platelet size before coronary angioplasty on subsequent restenosis. Eur J Clin Invest. 1993;23(6):361-367.

Slavka G, Perkmann T, Haslacher H, Greisenegger S, Marsik C, Wagner OF, et al. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol. 2011;31(5):1215-1218.

Khode V, Sindhur J, Kanbur D, Ruikar K, Nallulwar S. Mean platelet volume and other platelet volume indices in patients with stable coronary artery disease and acute myocardial infarction: A case control study. J Cardiovasc Dis Res. 2012;3(4):272-275.

Ghahremanfard F, Asghari N, Ghorbani R, Samaei A, Ghomi H, Tamadon M. The relationship between mean platelet volume and severity of acute ischemic brain stroke. Neurosciences (Riyadh). 2013;18(2):147-151.

Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events?. Stroke. 2004;35(7):1688-1691.

Bath P, Algert C, Chapman N, Neal B; PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke. 2004;35(3):622-626.

Dherma P. Hubungan antara Nilai Mean Platelet Volume (MPV) dan Kadar sP-Selectin Plasma dengan Kejadian Stroke Iskemik Akut. [Tesis] Universitas Andalas. 2015

Rosmiati B, Wibawa SY, Darmawaty ER. Mean platelet volume in stroke. Indonesian Journal of Clinical Pathology and Medical Laboratory. 2012;19(1):37-9.

Khaspekova SG, Ziuriaev IT, Iakushkin VV, Naimushin IA, Sirotkina OV, Zaitseva NO, Ruda ML, et al. Mean Platelet Volume: Interactions With Platelet Aggregation Activity and Glycoprotein IIb-IIIa and Ib Expression Levels Biomed Khim. 2014;60(1):94-108.

Arikanoglu A, Yucel Y, Acar A, Cevik MU, Akil E, Varol S. The relationship of the mean platelet volume and C-reactive protein levels with mortality in ischemic stroke patients. Eur Rev Med Pharmacol Sci. 2013;17(13):1774-1777.

Maxwell JR, Yadav R, Rossi RJ, Ruby CE, Weinberg AD, Aguila HL, et al. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. J Immunol. 2006;177(1):234-245.

Kaplanski G. Interleukin-18: Biological properties and role in disease pathogenesis. Immunol Rev. 2018;281(1):138-153.

Mulyani WRW, Sanjiwani MID, Sandra, Prabawa IPY, Lestari AAW, Wihandani DM, et al. Chaperone-Based Therapeutic Target Innovation: Heat Shock Protein 70 (HSP70) for Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes. 2020;13:559-568.

Artha IMJR, Bhargah A, Dharmawan NK, Pande UW, Triyana KA, Mahariski PA, et al. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus. Vasc Health Risk Manag. 2019;15:149-157.

Zaremba J, Losy J. Interleukin-18 in acute ischaemic stroke patients. Neurol Sci. 2003;24(3):117-124.


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0